{"meta":{"query_hash":"9d1c7172ce5d","filters":{"venue":"FarFar - Pharmacy Repository"},"cohort_total":5,"direct_labels_cover":0,"predictions_cover":5,"exported":5,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/9d1c7172ce5d","api":"https://metacan.xera.ac/api/v1/cohort?venue=FarFar+-+Pharmacy+Repository"},"results":[{"id":"W7132617467","doi":"","title":"Komparativna analiza promene sistema za refundaciju lekova i politike cena lekova u zemljama EU","year":2006,"lang":"","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Regional Development and Management Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"European union; European commission; Mercantilism; Quarter (Canadian coin)","score_opus":0.04510589546980879,"score_gpt":0.2550810434584335,"score_spread":0.20997514798862474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132617467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86171407,0.0066670505,0.021323664,0.004233309,0.000117539494,0.00021457826,0.009339697,0.0004190131,0.09597111],"genre_scores_gemma":[0.97335976,0.0017465396,0.0064177685,0.00017584332,0.000042523254,0.00010477848,0.0036593769,0.00015770989,0.014335657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99663734,0.0012896232,0.00031507545,0.0006069848,0.0007870159,0.0003639128],"domain_scores_gemma":[0.9897379,0.0056554405,0.0017113396,0.00094153796,0.001672843,0.0002808658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050806515,0.00033197165,0.0007721798,0.0035589747,0.0007073942,0.0071679004,0.00066616276,0.00067278545,0.019389352],"category_scores_gemma":[0.018204682,0.00030889,0.0006941765,0.0083362395,0.0008550659,0.003051954,0.0021710105,0.0010733616,0.0024151304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013318349,0.00047642726,0.49295557,0.0014945191,0.0008151592,0.0006316991,0.01556051,0.011575278,0.0022833333,0.10155404,0.030703781,0.34061787],"study_design_scores_gemma":[0.000109325745,0.0008600222,0.6967059,0.000782064,0.00087755313,0.00041172042,0.029407742,0.02305374,0.0065687285,0.06792755,0.1731613,0.00013438887],"about_ca_topic_score_codex":0.016590003,"about_ca_topic_score_gemma":0.013438385,"teacher_disagreement_score":0.019389352,"about_ca_system_score_codex":0.001973868,"about_ca_system_score_gemma":0.0021657085,"threshold_uncertainty_score":0.06486386},"labels":[],"label_agreement":null},{"id":"W7132860175","doi":"","title":"Biocompatible nanoemulsions as a tool for preclinical testing of CW-02-79, a pyrazoloquinolinone modulator of sigma-2 receptors: preformulation and formulation studies","year":2023,"lang":"en","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Pharmacological Receptor Mechanisms and Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biocompatible material; In vivo; Receptor; In vitro; Drug discovery; Preclinical testing","score_opus":0.08510945275508523,"score_gpt":0.3928485805724067,"score_spread":0.30773912781732143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132860175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97085696,0.004798796,0.021597654,0.00007846224,0.000062136845,0.00053509424,0.0005462194,0.00012565569,0.0013989493],"genre_scores_gemma":[0.9707144,0.004172218,0.02211532,0.00006038491,0.000023467594,0.00039026476,0.00047568086,0.000031134015,0.0020171592],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988616,0.000014420942,0.000014732517,0.000024458759,0.000042588097,0.000017618664],"domain_scores_gemma":[0.99988234,0.000021000762,0.00004541203,0.000009492273,0.000027638966,0.000014043019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004662928,0.00040631503,0.00020443497,0.00024555484,0.00010316457,0.0001758542,0.00017517942,0.00029328757,0.0005167407],"category_scores_gemma":[0.00021362056,0.0000962631,0.00019990097,0.00014339476,0.00021002823,0.00020561593,0.00012751807,0.00039461342,0.00019973103],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031872332,0.000034327393,0.000034095323,0.0000582692,0.0000020780892,0.000022043447,0.000011781792,0.00009400071,0.99840385,0.00004610546,0.000016917873,0.0012446706],"study_design_scores_gemma":[0.000010298098,0.0010793561,0.00033335036,0.000007752992,0.000011390512,0.000055669985,0.000008002808,0.00035737173,0.99672544,0.000016600603,0.0013910126,0.0000036328572],"about_ca_topic_score_codex":0.00043181897,"about_ca_topic_score_gemma":0.0005358081,"teacher_disagreement_score":0.0005167407,"about_ca_system_score_codex":0.00024374101,"about_ca_system_score_gemma":0.00016993219,"threshold_uncertainty_score":0.0024659634},"labels":[],"label_agreement":null},{"id":"W7132956291","doi":"","title":"Structural analysis of PEGylated nanoemulsions using EPR spectroscopy – the impact of an active compound incorporated in stabilizing layer","year":2023,"lang":"en","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Proteins in Food Systems","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Homogenizer; Bioavailability; Drug delivery; Polyvinyl alcohol; Phospholipid; Aqueous solution; Aqueous two-phase system; PEG ratio","score_opus":0.09693790705801955,"score_gpt":0.3679130291362785,"score_spread":0.2709751220782589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132956291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460983,0.000967081,0.0032548145,0.0000495242,0.000025225783,0.000027600907,0.0003178992,0.000039099006,0.0007088249],"genre_scores_gemma":[0.9914408,0.0010095253,0.005193811,0.000046565747,0.000007118772,0.00004336309,0.00055072916,0.000028384991,0.0016797124],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.999931,0.000007643502,0.000010195043,0.00001881197,0.000021395084,0.000011003503],"domain_scores_gemma":[0.99983466,0.000031212276,0.00005909897,0.000007877653,0.00004884994,0.000018224806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017464023,0.0002492539,0.00011186623,0.00020436208,0.00009588236,0.00012196577,0.0001296432,0.00020118285,0.0007451916],"category_scores_gemma":[0.0002048369,0.00008457812,0.00019523135,0.00013333441,0.00015799962,0.0002455471,0.00009251283,0.000318502,0.00019597252],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047567955,0.000010147603,0.00009010831,0.000024389541,0.0000025589957,0.000016655998,0.000016652091,0.000055511526,0.9991524,0.00001712288,0.000009770159,0.00055717584],"study_design_scores_gemma":[0.00000391196,0.00018797787,0.0019195204,0.0000048132706,0.0000070925666,0.000041139177,0.000022906574,0.0007066331,0.996648,0.000016771151,0.00043626397,0.0000049603987],"about_ca_topic_score_codex":0.00041903093,"about_ca_topic_score_gemma":0.00038481722,"teacher_disagreement_score":0.0007451916,"about_ca_system_score_codex":0.00011278932,"about_ca_system_score_gemma":0.000080798185,"threshold_uncertainty_score":0.002492845},"labels":[],"label_agreement":null},{"id":"W7132978064","doi":"","title":"Meta-analysis of the data on differences in the exposure to psychiatric drugs between poor and normal cYP2C19/CYP2D6 metabolizers","year":2022,"lang":"sr","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"CYP2C19; Pharmacogenetics; Psychosis; Significant difference","score_opus":0.24703097666292717,"score_gpt":0.42380895361854004,"score_spread":0.17677797695561287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7132978064","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03526069,0.94615275,0.0074283034,0.001046587,0.0012107957,0.0005429301,0.006495321,0.00017570538,0.0016868771],"genre_scores_gemma":[0.72091824,0.25352144,0.010357507,0.0029014419,0.00090157666,0.002064071,0.007024674,0.00026997755,0.0020410882],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9845861,0.008039056,0.003445268,0.0022058717,0.0013332142,0.00039046924],"domain_scores_gemma":[0.97134125,0.021591734,0.0028434054,0.0024951668,0.001457152,0.0002712473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016491879,0.0026269385,0.012942329,0.0040114704,0.00082177494,0.00335028,0.0016621548,0.0018580767,0.005150878],"category_scores_gemma":[0.042747594,0.0012784981,0.052894466,0.0059138355,0.00056965917,0.0014305613,0.0014989133,0.0027826075,0.0005050275],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031992781,0.000023302484,0.012953167,0.0403455,0.93272376,0.00013600237,0.000052695766,0.00064586895,0.00039312706,0.00020419121,0.0010082285,0.008314888],"study_design_scores_gemma":[0.00053692085,0.00021892952,0.011601319,0.0026351637,0.98133284,0.0001334914,0.000031987347,0.00026005568,0.00022748075,0.00051716564,0.0024852967,0.00001937976],"about_ca_topic_score_codex":0.004880609,"about_ca_topic_score_gemma":0.007779281,"teacher_disagreement_score":0.016491879,"about_ca_system_score_codex":0.00154629,"about_ca_system_score_gemma":0.0020652893,"threshold_uncertainty_score":0.087218404},"labels":[],"label_agreement":null},{"id":"W7133016376","doi":"","title":"A proposal of innovative injectability assessment method for intravenous formulations - case study on PEGylated nanoemulsions","year":2022,"lang":"en","type":"article","venue":"FarFar - Pharmacy Repository","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Homogenizer; Biocompatibility; Drug delivery; Compounding; Dosage form; Aqueous two-phase system; Critical quality attributes","score_opus":0.13086647737480456,"score_gpt":0.5091508657235977,"score_spread":0.37828438834879313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7133016376","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10358016,0.009823566,0.8681434,0.0011888912,0.00026809788,0.0016928021,0.00020617663,0.0012873124,0.0138096735],"genre_scores_gemma":[0.3710183,0.0072901077,0.60847706,0.00019444947,0.00012869865,0.00047228925,0.00016673087,0.00011598448,0.01213636],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990671,0.0001950008,0.000065167755,0.0001648635,0.00045897468,0.000048904327],"domain_scores_gemma":[0.9994504,0.00015743004,0.00007850418,0.000052597854,0.0002288205,0.000032194184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001688798,0.00074783765,0.00049940124,0.0012648002,0.00032986046,0.0012298082,0.0008004797,0.0015721142,0.0014228901],"category_scores_gemma":[0.0013044502,0.00029121368,0.00062086445,0.00059962354,0.00054301013,0.0013222628,0.0005326797,0.0006006406,0.000530041],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035027775,0.00038963254,0.003151266,0.0014604422,0.000037326983,0.0027751694,0.0005414351,0.009802234,0.6425583,0.009170664,0.0021484224,0.3276148],"study_design_scores_gemma":[0.000040257102,0.0015939542,0.0027828312,0.00018645468,0.000106114734,0.005509914,0.00030151007,0.110096544,0.8243068,0.0033087255,0.05161441,0.00015253034],"about_ca_topic_score_codex":0.0005033152,"about_ca_topic_score_gemma":0.00054228836,"teacher_disagreement_score":0.001688798,"about_ca_system_score_codex":0.00051732716,"about_ca_system_score_gemma":0.00041720123,"threshold_uncertainty_score":0.008931279},"labels":[],"label_agreement":null}]}